Have any thoughts about
Seagen Inc?
Write Note

Seagen Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Seagen Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
Seagen Inc
F:SGT
Total Equity
$2.6B
CAGR 3-Years
4%
CAGR 5-Years
13%
CAGR 10-Years
27%
Abbvie Inc
NYSE:ABBV
Total Equity
$6.8B
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.3B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
1%
Amgen Inc
NASDAQ:AMGN
Total Equity
$5.9B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
-13%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$14.8B
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$28.2B
CAGR 3-Years
23%
CAGR 5-Years
24%
CAGR 10-Years
28%

See Also

What is Seagen Inc's Total Equity?
Total Equity
2.6B USD

Based on the financial report for Sep 30, 2023, Seagen Inc's Total Equity amounts to 2.6B USD.

What is Seagen Inc's Total Equity growth rate?
Total Equity CAGR 10Y
27%

Over the last year, the Total Equity growth was -10%. The average annual Total Equity growth rates for Seagen Inc have been 4% over the past three years , 13% over the past five years , and 27% over the past ten years .

Back to Top